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Introduction
Urinary bladder cancer is the sixth most common 
cancer worldwide and the second most common 
malignancy of the genitourinary tract after prostate 
1,2
cancer . Estimated new cases and deaths from 
bladder cancer in the United States in 2016 were 
1
76,960 and 16,390 respectively . Transurethral 
resection of the bladder tumor (TURBT) is a 
therapeutic procedure that gives the material 
necessary for histopathological diagnosis with the 
degree of differentiation, and depth of tumor 
invasion, parameters useful in elaboration of 
2
diagnosis and prognosis assessment . This study 
aimed to show the epidemiological profile of 
patients who had TURBT and the various 
histological types of bladder tumour at presentation.
Methodology
This was a retrospective study on patients who had 
undergone Transurethral Resection of Bladder 
Tumor (TURBT) at B.P  Koirala Institute of Health 
Sciences Dharan, Nepal during time period from 
November, 2007 to March, 2016. Data of patients 
were obtained from the medical record section and 
information about the age, sex, history of smoking 
,exposure to other possible risk factors, clinical 
presentations, blood investigation, operative 
findings and histopathological diagnosis were 
retrieved. The collected data were entered in a 
structured proforma and was analyzed using 
Statistical Package For Social Sciences (SPSS) 
software version 17.0.
Results
A total  of  fifty-five (55) patients  had trans- urethral 
resection of bladder tumor (TURBT)  in the years 
17Jos Journal of Medicine, Volume 11, No. 1 
TRANSURETHRAL RESECTION OF BLADDER TUMOUR (TURBT) : EXPERIENCE OF A 
TERTIARY CENTRE
1 2 1
Niraj T , Agbo CA , Agrawal CS
1. B. P. Koirala Institute of Health Sciences, Department of Surgery Dharan, Nepal.





Objective: To show the epidemiological profile of patients who had transurethral resection of bladder 
tumours and the various histological types of bladder tumour at presentation.
Methodology: A retrospective study on patients who had transurethral resection of bladder tumor (TURBT) 
at  B.P  Koirala Institute of Health Sciences Dharan, Nepal between the time period of November, 2007 and 
March, 2016. Information were retrieved from the record and entered in a structured proforma and analyzed 
using Statistical Package for Social Sciences (SPSS) software version 17.0.
Results: Fifty-five patients with urinary bladder tumour had transurethral resection of bladder tumor 
(TURBT) within the years under review. The mean age was 61.6 years and smoking was found as the major 
risk factor (P < 0.05) for high grade Transition cell carcinoma (TCC). Farming (45%) was the commonest 
type of occupation and hematuria (95%) as the commonest presenting symptom . Transitional Cell 
Carcinoma was the commonest histological variety in our study accounting for 85.5% of cases with majority 
(78%) as non-muscle invasive. The muscle invasion was directly associated with the grade of tumor.
Conclusion: Bladder tumour is a common genitourinary condition with transurethral resection of bladder 
tumor  (TURBT) being effective in giving the degree of differentiation, depth of tumor invasion, parameters 
useful in diagnosis, treatment and prognosis assessment.
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under review with male female ratio of 3.6:1. The 
age of the patient at presentation ranged from 30-80 
years with the mean age of 61.6. Most of the patients 
with bladder carcinoma were between 60 and 70 
years of the age. The major occupation among the 
patients were farming (45%).
Regarding clinical features of the patients, 
hematuria was the most common symptom (95%) at 
the time of presentation among which 48 (87.3%) 
patients were having painless hematuria and 7 
(12.7%) patients had painful hematuria . There was a 
significant correlation between smoking and grade 
of TCC (P<0.05) . The operative findings were 
dominantly of proliferative growth (32.7%) 
followed by polypoidal growth (30.9%), followed 
by papillary growth (10.9%). The most common site 
being lateral wall 34.5% .Transitional Cell 
Carcinoma (TCC) was the most common 
histological variety of bladder cancer in our study 
accounting for 85.5%  of which 12 (21.8%) patients 
had high grade and 35 (63.6%) patients had low 
grade tumor  as shown in Table 1 below. 
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Table 1: Showing Histological Diagnosis  
Histology Muscle invasion Total   
Percentage  
Present Absent  
Benign  conditions 0 8 8  14.6  
Low grade Papillary urothelial 
cancer 
9 26 35  63.6  
High grade Papillary urothelial 
cancer 
11 1 12  21.8  
Total 20 35 55  100.0  
 
Discussion
Urinary bladder cancer is commonly seen in males 
3,4than in females (M:F = 3:1) . The present study also 
shows a similar distribution pattern (M:F = 3.6:1). 
Furthermore, studies done in Malaysia and India 
revealed higher M:F ratio of 9.4:1 and 8.6:1 
respectively which shows male preponderance. This 
shows that as similar to other part of the world, in 
Nepal also, incidence of bladder cancer  is high in 
male than in female. The reason for higher incidence 
in males could be attributed to environmental, 
dietary exposure, anatomical difference, urinary 
habits and hormonal factors whereas, less incidence 
of bladder cancer in females could be due to less 
exposure of females to individual carcinogens and 
5,6,7less smoking .
Most of the patients with bladder carcinoma are 
between 60 and 80 years of the age with mean age of 
61.6. This is similar to that obtained by Joshi HN et 
8
al  in which most of patient of bladder tumor were 
between 50 and 70 yrs of age.
The most common clinical manifestation was found 
6,9to be a painless hematuria . In the present study, 
hematuria was found to be the most common clinical 
feature. In support to the present finding, a study 
done in India and Pakistan has shown that 97%, 
81.4%, 88.7% of the patients had hematuria as 
4,6
presenting symptom .
In present study significant impact of smoking has 
been found as a major risk factor (P < 0.05) for high 
grade Transition cell carcinoma (TCC) in which out 
of 35 cases of bladder cancer with the history of 
smoking, 31(88%) were found to have high grade 
TCC , which is similar to the result of study carried 
10
out by Ray et al  in which 72% of the patients with 
bladder carcinoma were smokers in developing of 
high grade TCC. 
The study showed 85.5%  patient had urothelial 
(TCC) carcinoma out of which 22 % had muscle 
invasive carcinoma and the muscle invasion was 
related with high grade transitional carcinoma (P < 
0.05). This is comparable to finding by Pudasaini  et 
11al  which showed among the malignant lesion of 
urinary bladder , 88.9% were urothelial tumor of 
which 25% cases showed muscle invasion.
Conclusion
The peak age incidence of bladder cancer was 
seventh decade of life with male preponderance and 
smoking as the major risk factor. Painless hematuria 
was the most common initial presentation . The 
operative findings were predominantly of single 
proliferative growth followed by polypoidal growth 
in the lateral wall of bladder. Transitional Cell 
Carcinoma was the most common histological 
variety of bladder cancer in our study accounting for 
85.6% of cases with majority (78%)  being non- 
muscle invasive. The muscle invasion was directly 
associated with the grade of tumor.
Transurethral resection of bladder tumour  
(TURBT) has a great impact in bladder tumour 
management as it gives the degree of differentiation, 
depth of tumor invasion, parameters useful in 
diagnosis, treatment and prognosis assessment.
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